Stephen R. Davis
2019
In 2019, Stephen R. Davis earned a total compensation of $7.6M as Chief Executive Officer at ACADIA Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $597,485 |
|---|---|
| Option Awards | $3,127,738 |
| Salary | $743,705 |
| Stock Awards | $3,140,000 |
| Other | $22,318 |
| Total | $7,631,245 |
Davis received $3.1M in stock awards, accounting for 41% of the total pay in 2019.
Davis also received $597.5K in non-equity incentive plan, $3.1M in option awards, $743.7K in salary and $22.3K in other compensation.
Rankings
In 2019, Stephen R. Davis' compensation ranked 1,189th out of 13,971 executives tracked by ExecPay. In other words, Davis earned more than 91.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,189 out of 13,971 | 92nd |
Division Manufacturing | 412 out of 5,701 | 93rd |
Major group Chemicals And Allied Products | 124 out of 2,200 | 94th |
Industry group Drugs | 99 out of 1,886 | 95th |
Industry Pharmaceutical Preparations | 74 out of 1,398 | 95th |
Source: SEC filing on April 30, 2021.
Davis' colleagues
We found four more compensation records of executives who worked with Stephen R. Davis at ACADIA Pharmaceuticals in 2019.